Mesangial proliferative glomerulonephritis is a hard condition to treat. The regular treatments only focus on treating high blood pressure, proteinuria, high cholesterol levels and other symptoms. However, those treatments alone is not enough to stop the condition from progressing.
Bird flu vaccine. The Food and Drug Administration has approved one vaccine to prevent infection with one strain of H5N1 bird flu virus. This vaccine isn't available to the public, but the U.S. government is stockpiling it and will distribute it in the event of an outbreak.
TUESDAY, Oct. 3, 2017 (HealthDay News) -- Scientists have pinpointed a mechanism that helps flu viruses mutate rapidly, which could lead to new ways to fight the flu. Because flu viruses mutate quickly, flu vaccines have to be redesigned every year. The MIT researchers found that to mutate rapidly, flu viruses use a group of proteins called chaperones in infected cells in the host (a person or animal with the flu). Blocking flu viruses from using the host cells' chaperones could help prevent the viruses from developing resistance to existing drugs and vaccines, the study authors said.